Events

These events and webinars are intended for veterinary professionals only.

Event
Date and location

Zennovation in Sedation: Rethinking What is Possible #23044

Speaker:
Jennifer Kasten, DVM

In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).

07:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-918761

Wednesday, February 1, 2023, 19:00 - 20:00
location_on Dinner Meeting, Lancaster, PA

Register now

View website

Zennovation in Sedation: Rethinking What is Possible #23043

Speaker:
Jennifer Kasten, DVM

In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).

07:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-918761

Management of the Broodmare #23008

Speaker:
Hadley Whiting, DVM

The presenter will discuss the routine care the mare requires throughout the year. Topics will include preparing the mare through anestrus to managing her cycle to conception. The medications and tools used in the breeding shed will be discussed along with maintenance considerations for the pregnant mare from conception to foaling.

07:00 PM EST

RACE# 27059-898393

1 RACE-Approved Credit Hour
 

Tuesday, February 7, 2023, 19:00 - 20:00
location_on Virtual Meeting

Register now

Zennovation in Sedation: Rethinking What is Possible #23042

Speaker:
Jim Lowe, DVM

In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).

07:00 PM CST

1 RACE-Approved Credit  

RACE# 27059-918761

Zennovation in Sedation: Rethinking What is Possible #23009

Speaker:
Jim Lowe, DVM

In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).

07:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-918761

Thursday, February 9, 2023, 19:00 - 20:00
location_on Virtual Meeting

Register now

Update on Managing Canine Hyperadrenocorticism #23010

Speaker:
Kathy Engler, DVM, DABVP

Canine Hyperadrenocorticism (Cushing’s Disease) can be a challenging yet rewarding disease to manage. This presentation will review all aspects of Cushing’s: basic pathophysiology, clinical signs, diagnostics, differentiating tests, treatment and monitoring. A series of cases to increase  understanding of managing Cushing’s patients will be presented and the final  section highlights ways to  enhance owner compliance. 

07:00 PM EST

1.5 RACE-Approved Credits  

RACE# 27059-869593 

Wednesday, February 15, 2023, 19:00 - 20:00
location_on Virtual Meeting

Register now

Zennovation in Sedation: Rethinking What is Possible #23059

Speaker:
Mike LaRosh, DVM

In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).

07:00 PM MST

1 RACE-Approved Credit  

RACE# 27059-918761

Wednesday, February 15, 2023, 19:00 - 20:00
location_on Dinner Meeting, Denver, CO

Register now

View website

Zennovation in Sedation: Rethinking What is Possible #23052

Speaker:
Jennifer Kasten, DVM

In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).

07:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-918761

Zennovation in Sedation: Rethinking What is Possible #23060

Speaker:
Mike LaRosh, DVM

In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).

07:00 PM MST

1 RACE-Approved Credit  

RACE# 27059-918761

Thursday, February 16, 2023, 19:00 - 20:00
location_on Dinner Meeting, Lakewood, CO

Register now

View website

Update on Managing Canine Hyperadrenocorticism #23011

Speaker:
Timothy Smaha, DVM

Canine Hyperadrenocorticism (Cushing’s Disease) can be a challenging yet rewarding disease to manage. This presentation will review all aspects of Cushing’s: basic pathophysiology, clinical signs, diagnostics, differentiating tests, treatment and monitoring. A series of cases to increase  understanding of managing Cushing’s patients will be presented and the final  section highlights ways to  enhance owner compliance. 

10:00 PM EST

1.5 RACE-Approved Credits  

RACE# 27059-869593 

Thursday, February 16, 2023, 22:00 - 23:30
location_on Virtual Meeting

Register now

Verdinexor: A Novel Oral Therapy for Canine Lymphoma #23064

Speaker:
Kathy Engler, DVM, DABVP

This lecture will discuss the novel class of drugs called SINE inhibitors, with emphasis on verdinexor (Laverdia-CA1). We will review SINE mechanism of action, along with a thorough review of the data leading to a reasonable expectation of efficacy and FDA conditional approval of Laverdia-CA1. We will also look at where this new oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor the lymphoma patient on verdinexor, including how to address any potential adverse events. 

7:00 PM PST

1 RACE-Approved Credit  

RACE# 27059-900255 

Tuesday, February 21, 2023, 19:00 - 20:00
location_on Dinner Meeting, Seattle, WA

Register now

View website

Zennovation in Sedation: Rethinking What is Possible #23012

Speaker:
Kathy Engler, DVM, DABVP

In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).

10:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-918761

Tuesday, February 21, 2023, 22:00 - 23:00
location_on Virtual Meeting

Register now

Verdinexor: A Novel Oral Therapy for Canine Lymphoma #23063

Speaker:
Kathy Engler, DVM, DABVP

This lecture will discuss the novel class of drugs called SINE inhibitors, with emphasis on verdinexor (Laverdia-CA1). We will review SINE mechanism of action, along with a thorough review of the data leading to a reasonable expectation of efficacy and FDA conditional approval of Laverdia-CA1. We will also look at where this new oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor the lymphoma patient on verdinexor, including how to address any potential adverse events. 

7:00 PM PST

1 RACE-Approved Credit  

RACE# 27059-900255 

Wednesday, February 22, 2023, 19:00 - 20:00
location_on Dinner Meeting, Woodinville, WA

Register now

View website

Zennovation in Sedation: Rethinking What is Possible #23077

Speaker:
Elizabeth Mongol-Gunter, VMD

In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).

07:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-918761

Zennovation in Sedation: Rethinking What is Possible #23080

Speaker:
Gregory Long, DVM

In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).

07:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-918761

Wednesday, February 22, 2023, 19:00 - 20:00
location_on Dinner Meeting, Clearwater, FL

Register now

View website

Verdinexor: A Novel Oral Therapy for Canine Lymphoma & Zennovation in Sedation: Rethinking What is Possible #23065

Speaker:
Kathy Engler, DVM, DABVP

Zennovation in Sedation: Rethinking What is Possible

In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).

Verdinexor: A Novel Oral Therapy for Canine Lymphoma 

This lecture will discuss the novel class of drugs called SINE inhibitors, with emphasis on verdinexor (Laverdia-CA1). We will review SINE mechanism of action, along with a thorough review of the data leading to a reasonable expectation of efficacy and FDA conditional approval of Laverdia-CA1. We will also look at where this new oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor the lymphoma patient on verdinexor, including how to address any potential adverse events. 

7:00 PM PST

2 RACE-Approved Credit 

Thursday, February 23, 2023, 19:00 - 20:00
location_on Dinner Meeting, Seattle, WA

Register now

View website

Verdinexor: A Novel Oral Therapy for Canine Lymphoma #23013

Speaker:
Pam Mitchell, MS, DVM

This lecture will discuss the novel class of drugs called SINE inhibitors, with emphasis on verdinexor (Laverdia-CA1). We will review SINE mechanism of action, along with a thorough review of the data leading to a reasonable expectation of efficacy and FDA conditional approval of Laverdia-CA1. We will also look at where this new oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor the lymphoma patient on verdinexor, including how to address any potential adverse events. 

02:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-900255 

Tuesday, February 28, 2023, 14:00 - 15:00
location_on Virtual Meeting

Register now

Zennovation in Sedation: Rethinking What is Possible #23014

Speaker:
Jennifer Kasten, DVM

In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).

02:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-918761

Thursday, March 2, 2023, 14:00 - 15:00
location_on Virtual Meeting

Register now

Update on Managing Canine Hyperadrenocorticism #23015

Speaker:
Bridget Fitzpatrick, DVM

Canine Hyperadrenocorticism (Cushing’s Disease) can be a challenging yet rewarding disease to manage. This presentation will review all aspects of Cushing’s: basic pathophysiology, clinical signs, diagnostics, differentiating tests, treatment and monitoring. A series of cases to increase understanding of managing Cushing’s patients will be presented and the final section highlights ways to enhance owner compliance.

12:00 PM EST

1.5 RACE-Approved Credit  

RACE# 27059-869593

Tuesday, March 14, 2023, 12:00 - 13:30
location_on Virtual Meeting

Register now

Zennovation in Sedation: Rethinking What is Possible #23071

Speaker:
Kathy Engler, DVM, DABVP

In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).

07:00 PM Central

1 RACE-Approved Credit  

RACE# 27059-918761

Zennovation in Sedation: Rethinking What is Possible #23076

Speaker:
Gregory Long, DVM

In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).

07:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-918761

Zennovation in Sedation: Rethinking What is Possible and Verdinexor: A Novel Oral Therapy for Canine Lymphoma #23072

Speaker:
Kathy Engler, DVM, DABVP

In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).

Part 2: This lecture will discuss the novel class of drugs called SINE inhibitors, with emphasis on verdinexor (Laverdia-CA1). We will review SINE mechanism of action, along with a thorough review of the data leading to a reasonable expectation of efficacy and FDA conditional approval of Laverdia-CA1. We will also look at where this new oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor the lymphoma patient on verdinexor, including how to address any potential adverse events.

1:00 PM Central

2 RACE-Approved Credit  

Wednesday, March 15, 2023, 13:00 - 15:00
location_on Dinner Meeting, Brook, IL

Register now

View website

Verdinexor: A Novel Oral Therapy for Canine Lymphoma #23016

Speaker:
Jim Lowe, DVM

This lecture will discuss the novel class of drugs called SINE inhibitors, with emphasis on verdinexor (Laverdia-CA1). We will review SINE mechanism of action, along with a thorough review of the data leading to a reasonable expectation of efficacy and FDA conditional approval of Laverdia-CA1. We will also look at where this new oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor the lymphoma patient on verdinexor, including how to address any potential adverse events. 

07:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-900255 

Wednesday, March 15, 2023, 19:00 - 20:00
location_on Virtual Meeting

Register now

Zennovation in Sedation: Rethinking What is Possible #23088

Speaker:
Gregory Long, DVM

In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).

07:00 PM EDT

1 RACE-Approved Credit  

RACE# 27059-918761

Zennovation in Sedation: Rethinking What is Possible #23066

Speaker:
Kathy Engler, DVM, DABVP

In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).

07:00 PM Central

1 RACE-Approved Credit  

RACE# 27059-918761

Zennovation in Sedation: Rethinking What is Possible #23069

Speaker:
James Sturzione, DVM, MBS

In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).

06:30 PM EST

1 RACE-Approved Credit  

RACE# 27059-918761

Zennovation in Sedation: Rethinking What is Possible #23068

Speaker:
James Sturzione, DVM, MBS

In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).

06:00 PM EDT

1 RACE-Approved Credit  

RACE# 27059-918761

Zennovation in Sedation: Rethinking What is Possible #23092

Speaker:
Kathy Engler, DVM, DABVP

In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).

07:00 PM CDT

1 RACE-Approved Credit  

RACE# 27059-918761

Verdinexor: A Novel Oral Therapy for Canine Lymphoma #23093

Speaker:
Kathy Engler, DVM, DABVP

This lecture will discuss the novel class of drugs called SINE inhibitors, with emphasis on verdinexor (Laverdia-CA1). We will review SINE mechanism of action, along with a thorough review of the data leading to a reasonable expectation of efficacy and FDA conditional approval of Laverdia-CA1. We will also look at where this new oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor the lymphoma patient on verdinexor, including how to address any potential adverse events. 

07:00 PM CDT

1 RACE-Approved Credit  

RACE# 27059-900255 

Canine Otitis Externa: Diagnosis, Management, and Success #23017

Speaker:
Gregory Long, DVM

Canine otitis externa is one of the most frequently encountered conditions in small animal veterinary practice. This presentation explores the causes of canine otitis externa including the predisposing, primary and perpetuating factors, the importance of otic cytology, and the essential treatment modalities to help ensure clinical resolution. The development of a long-term maintenance cleaning and allergy management plan will also be discussed.

10:00 PM EST

RACE# 27059-963682
1 RACE-Approved Credit Hour

Thursday, March 23, 2023, 22:00 - 23:00
location_on Virtual Meeting

Register now

Zennovation in Sedation: Rethinking What is Possible #23073

Speaker:
Jennifer Kasten, DVM

In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).

07:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-918761

Maximizing Topical Therapy in Companion Animal Practice #23018

Speaker:
Julie Kluxdal, DVM

With dermatologic conditions making up a large volume of the caseload in companion animal medicine and with antimicrobial resistance on the rise, topical therapies need to play a bigger role in dermatologic therapy. This presentation will discuss why topical therapies are helpful and how cytology helps guide topical product choice. The most common active ingredients in topical products for companion animals will be highlighted including their mechanism of action and suggested use. By having a complete understanding of active ingredients, veterinarians will be better equipped to make a topical product selection. Compliance strategies will be discussed to help ensure that what a veterinarian prescribes actually gets used.

12:00 PM EST

RACE# 27059-906349

1 RACE-Approved Credit Hour

Thursday, March 30, 2023, 12:00 - 13:00
location_on Virtual Meeting

Register now

Verdinexor: A Novel Oral Therapy for Canine Lymphoma #23019

Speaker:
Gregory Long, DVM

This lecture will discuss the novel class of drugs called SINE inhibitors, with emphasis on verdinexor (Laverdia-CA1). We will review SINE mechanism of action, along with a thorough review of the data leading to a reasonable expectation of efficacy and FDA conditional approval of Laverdia-CA1. We will also look at where this new oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor the lymphoma patient on verdinexor, including how to address any potential adverse events. 

07:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-900255 

Wednesday, April 5, 2023, 19:00 - 20:00
location_on Virtual Meeting

Register now

Zennovation in Sedation: Rethinking What is Possible #23020

Speaker:
Elizabeth Mongol-Gunter, VMD

In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).

07:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-918761

Wednesday, April 12, 2023, 19:00 - 20:00
location_on Virtual Meeting

Register now

Canine Otitis Externa: Diagnosis, Management, and Success #23021

Speaker:
Bridget Fitzpatrick, DVM

Canine otitis externa is one of the most frequently encountered conditions in small animal veterinary practice. This presentation explores the causes of canine otitis externa including the predisposing, primary and perpetuating factors, the importance of otic cytology, and the essential treatment modalities to help ensure clinical resolution. The development of a long-term maintenance cleaning and allergy management plan will also be discussed.

12:00 PM EST

RACE# 27059-963682
1 RACE-Approved Credit Hour

Tuesday, April 18, 2023, 12:00 - 13:00
location_on Virtual Meeting

Register now

Verdinexor: A Novel Oral Therapy for Canine Lymphoma #23081

Speaker:
Julie Kluxdal, DVM

This lecture will discuss the novel class of drugs called SINE inhibitors, with emphasis on verdinexor (Laverdia-CA1). We will review SINE mechanism of action, along with a thorough review of the data leading to a reasonable expectation of efficacy and FDA conditional approval of Laverdia-CA1. We will also look at where this new oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor the lymphoma patient on verdinexor, including how to address any potential adverse events. 

07:00 PM PDT

1 RACE-Approved Credit  

RACE# 27059-900255 

Maximizing Topical Therapy in Companion Animal Practice #23022

Speaker:
Mike LaRosh, DVM

With dermatologic conditions making up a large volume of the caseload in companion animal medicine and with antimicrobial resistance on the rise, topical therapies need to play a bigger role in dermatologic therapy. This presentation will discuss why topical therapies are helpful and how cytology helps guide topical product choice. The most common active ingredients in topical products for companion animals will be highlighted including their mechanism of action and suggested use. By having a complete understanding of active ingredients, veterinarians will be better equipped to make a topical product selection. Compliance strategies will be discussed to help ensure that what a veterinarian prescribes actually gets used.

10:00 PM EST

RACE# 27059-906349

1 RACE-Approved Credit Hour

Tuesday, April 25, 2023, 20:00 - 21:00
location_on Virtual Meeting

Register now

Verdinexor: A Novel Oral Therapy for Canine Lymphoma #23082

Speaker:
Julie Kluxdal, DVM

This lecture will discuss the novel class of drugs called SINE inhibitors, with emphasis on verdinexor (Laverdia-CA1). We will review SINE mechanism of action, along with a thorough review of the data leading to a reasonable expectation of efficacy and FDA conditional approval of Laverdia-CA1. We will also look at where this new oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor the lymphoma patient on verdinexor, including how to address any potential adverse events. 

07:00 PM PDT

1 RACE-Approved Credit  

RACE# 27059-900255 

Wednesday, April 26, 2023, 19:00 - 20:00
location_on Dinner Meeting, Chico, CA

Register now

View website

Verdinexor: A Novel Oral Therapy for Canine Lymphoma #23023

Speaker:
Jim Lowe, DVM

This lecture will discuss the novel class of drugs called SINE inhibitors, with emphasis on verdinexor (Laverdia-CA1). We will review SINE mechanism of action, along with a thorough review of the data leading to a reasonable expectation of efficacy and FDA conditional approval of Laverdia-CA1. We will also look at where this new oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor the lymphoma patient on verdinexor, including how to address any potential adverse events. 

02:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-900255 

Tuesday, May 2, 2023, 14:00 - 15:00
location_on Virtual Meeting

Register now

Equine Regenerative Therapy - Autologous Blood Products #23024

Speaker:
Brett Robinson, DVM

The presenter reviews equine regenerative therapy. Focus areas include basic principles of regenerative medicine, FDA regulations, and types of autologous blood products. The types of medical devices necessary for processing autologous blood products including centrifugation, filtration, and incubation are all discussed. Additionally, a meta-analysis of current research with regards to platelet rich plasma (PRP), autologous conditioned serum (ACS), autologous protein solutions (APS), and alpha 2 macroglobulin will be analyzed.

RACE# 27059-924918

1 RACE-Approved Credit Hour

07:00 PM

Wednesday, May 3, 2023, 19:00 - 20:00
location_on Virtual Meeting

Register now

Canine Otitis Externa: Diagnosis, Management, and Success #23025

Speaker:
Timothy Smaha, DVM

Canine otitis externa is one of the most frequently encountered conditions in small animal veterinary practice. This presentation explores the causes of canine otitis externa including the predisposing, primary and perpetuating factors, the importance of otic cytology, and the essential treatment modalities to help ensure clinical resolution. The development of a long-term maintenance cleaning and allergy management plan will also be discussed.

07:00 PM EST

RACE# 27059-963682
1 RACE-Approved Credit Hour

Wednesday, May 10, 2023, 19:00 - 20:00
location_on Virtual Meeting

Register now

Zennovation in Sedation: Rethinking What is Possible #23026

Speaker:
Jennifer Kasten, DVM

In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).

12:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-918761

Tuesday, May 16, 2023, 12:00 - 13:00
location_on Virtual Meeting

Register now

Update on Managing Canine Hyperadrenocorticism #23027

Speaker:
Jennifer Kasten, DVM

Canine Hyperadrenocorticism (Cushing’s Disease) can be a challenging yet rewarding disease to manage. This presentation will review all aspects of Cushing’s: basic pathophysiology, clinical signs, diagnostics, differentiating tests, treatment and monitoring. A series of cases to increase  understanding of managing Cushing’s patients will be presented and the final  section highlights ways to  enhance owner compliance. 

02:00 PM EST

1.5 RACE-Approved Credits  

RACE# 27059-869593 

Wednesday, May 17, 2023, 14:00 - 15:00
location_on Virtual Meeting

Register now

Maximizing Topical Therapy in Companion Animal Practice #23028

Speaker:
James Sturzione, DVM, MBS

With dermatologic conditions making up a large volume of the caseload in companion animal medicine and with antimicrobial resistance on the rise, topical therapies need to play a bigger role in dermatologic therapy. This presentation will discuss why topical therapies are helpful and how cytology helps guide topical product choice. The most common active ingredients in topical products for companion animals will be highlighted including their mechanism of action and suggested use. By having a complete understanding of active ingredients, veterinarians will be better equipped to make a topical product selection. Compliance strategies will be discussed to help ensure that what a veterinarian prescribes actually gets used.

02:00 PM EST

RACE# 27059-906349

1 RACE-Approved Credit Hour

Thursday, May 25, 2023, 14:00 - 15:00
location_on Virtual Meeting

Register now

Verdinexor: A Novel Oral Therapy for Canine Lymphoma #23029

Speaker:
James Sturzione, DVM, MBS

This lecture will discuss the novel class of drugs called SINE inhibitors, with emphasis on verdinexor (Laverdia-CA1). We will review SINE mechanism of action, along with a thorough review of the data leading to a reasonable expectation of efficacy and FDA conditional approval of Laverdia-CA1. We will also look at where this new oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor the lymphoma patient on verdinexor, including how to address any potential adverse events. 

07:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-900255 

Thursday, June 1, 2023, 19:00 - 20:00
location_on Virtual Meeting

Register now

It's About Perfusion #23030

Speaker:
Mike LaRosh, DVM

This presentation will review the components of an appropriate fluid plan including why fluids are useful, which fluid, and how to calculate the correct volume and rate. In addition, monitoring guidelines to ensure the fluid plan is adequate and appropriate will be discussed. Participants will also learn about the endothelial glycocalyx and its important role in maintaining normal vascular function.

RACE# 27059-743915

1 RACE-Approved Credit Hour

10 PM EST

Tuesday, June 6, 2023, 22:00 - 23:00
location_on Virtual Meeting

Register now

Canine Otitis Externa: Diagnosis, Management, and Success #23031

Speaker:
Elizabeth Mongol-Gunter, VMD

Canine otitis externa is one of the most frequently encountered conditions in small animal veterinary practice. This presentation explores the causes of canine otitis externa including the predisposing, primary and perpetuating factors, the importance of otic cytology, and the essential treatment modalities to help ensure clinical resolution. The development of a long-term maintenance cleaning and allergy management plan will also be discussed.

02:00 PM EST

RACE# 27059-963682

1 RACE-Approved Credit Hour 
 

Tuesday, June 13, 2023, 14:00 - 15:00
location_on Virtual Meeting

Register now

Maximizing Topical Therapy in Companion Animal Practice #23032

Speaker:
Mike LaRosh, DVM

With dermatologic conditions making up a large volume of the caseload in companion animal medicine and with antimicrobial resistance on the rise, topical therapies need to play a bigger role in dermatologic therapy. This presentation will discuss why topical therapies are helpful and how cytology helps guide topical product choice. The most common active ingredients in topical products for companion animals will be highlighted including their mechanism of action and suggested use. By having a complete understanding of active ingredients, veterinarians will be better equipped to make a topical product selection. Compliance strategies will be discussed to help ensure that what a veterinarian prescribes actually gets used.

07:00 PM EST

RACE# 27059-906349

1 RACE-Approved Credit Hour

Wednesday, June 21, 2023, 19:00 - 20:00
location_on Virtual Meeting

Register now

Zennovation in Sedation: Rethinking What is Possible #23033

Speaker:
Julie Kluxdal, DVM

In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).

07:00 PM EST

1 RACE-Approved Credit  

RACE# 27059-918761

Thursday, June 29, 2023, 19:00 - 20:00
location_on Virtual Meeting

Register now

keyboard_arrow_up